235 related articles for article (PubMed ID: 20949975)
21. The cellular prion protein mediates neurotoxic signalling of β-sheet-rich conformers independent of prion replication.
Resenberger UK; Harmeier A; Woerner AC; Goodman JL; Müller V; Krishnan R; Vabulas RM; Kretzschmar HA; Lindquist S; Hartl FU; Multhaup G; Winklhofer KF; Tatzelt J
EMBO J; 2011 May; 30(10):2057-70. PubMed ID: 21441896
[TBL] [Abstract][Full Text] [Related]
22. Biophysical characterization of oligomerization and fibrillization of the G131V pathogenic mutant of human prion protein.
Zhang M; Zhang H; Yao H; Guo C; Lin D
Acta Biochim Biophys Sin (Shanghai); 2019 Dec; 51(12):1223-1232. PubMed ID: 31735962
[TBL] [Abstract][Full Text] [Related]
23. The P's and Q's of cellular PrP-Aβ interactions.
Westaway D; Jhamandas JH
Prion; 2012; 6(4):359-63. PubMed ID: 22874673
[TBL] [Abstract][Full Text] [Related]
24. Dynamics of a truncated prion protein, PrP(113-231), from (15)N NMR relaxation: order parameters calculated and slow conformational fluctuations localized to a distinct region.
O'Sullivan DB; Jones CE; Abdelraheim SR; Brazier MW; Toms H; Brown DR; Viles JH
Protein Sci; 2009 Feb; 18(2):410-23. PubMed ID: 19173221
[TBL] [Abstract][Full Text] [Related]
25. Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form.
Vanik DL; Surewicz WK
J Biol Chem; 2002 Dec; 277(50):49065-70. PubMed ID: 12372829
[TBL] [Abstract][Full Text] [Related]
26. Metadynamics simulation of prion protein: beta-structure stability and the early stages of misfolding.
Barducci A; Chelli R; Procacci P; Schettino V; Gervasio FL; Parrinello M
J Am Chem Soc; 2006 Mar; 128(8):2705-10. PubMed ID: 16492057
[TBL] [Abstract][Full Text] [Related]
27. DNA converts cellular prion protein into the beta-sheet conformation and inhibits prion peptide aggregation.
Cordeiro Y; Machado F; Juliano L; Juliano MA; Brentani RR; Foguel D; Silva JL
J Biol Chem; 2001 Dec; 276(52):49400-9. PubMed ID: 11604397
[TBL] [Abstract][Full Text] [Related]
28. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
Liemann S; Glockshuber R
Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
[TBL] [Abstract][Full Text] [Related]
29. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice.
Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443
[TBL] [Abstract][Full Text] [Related]
30. The intrinsic stability of the human prion β-sheet region investigated by molecular dynamics.
De Simone A; Stanzione F; Marasco D; Vitagliano L; Esposito L
J Biomol Struct Dyn; 2013; 31(5):441-52. PubMed ID: 22876967
[TBL] [Abstract][Full Text] [Related]
31. Prion protein misfolding.
Kupfer L; Hinrichs W; Groschup MH
Curr Mol Med; 2009 Sep; 9(7):826-35. PubMed ID: 19860662
[TBL] [Abstract][Full Text] [Related]
32. Cryo-EM structure of an amyloid fibril formed by full-length human prion protein.
Wang LQ; Zhao K; Yuan HY; Wang Q; Guan Z; Tao J; Li XN; Sun Y; Yi CW; Chen J; Li D; Zhang D; Yin P; Liu C; Liang Y
Nat Struct Mol Biol; 2020 Jun; 27(6):598-602. PubMed ID: 32514176
[TBL] [Abstract][Full Text] [Related]
33. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation.
Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G
J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748
[TBL] [Abstract][Full Text] [Related]
34. Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: potentials and limitations.
Kim Y; Han B; Titlow W; Mays CE; Kwon M; Ryou C
Antiviral Res; 2009 Nov; 84(2):185-93. PubMed ID: 19748523
[TBL] [Abstract][Full Text] [Related]
35. The role of Cys179-Cys214 disulfide bond in the stability and folding of prion protein: insights from molecular dynamics simulations.
Ning L; Guo J; Jin N; Liu H; Yao X
J Mol Model; 2014 Feb; 20(2):2106. PubMed ID: 24515720
[TBL] [Abstract][Full Text] [Related]
36. The determinants of stability in the human prion protein: insights into folding and misfolding from the analysis of the change in the stabilization energy distribution in different conditions.
Colacino S; Tiana G; Broglia RA; Colombo G
Proteins; 2006 Mar; 62(3):698-707. PubMed ID: 16432880
[TBL] [Abstract][Full Text] [Related]
37. Impact of methionine oxidation as an initial event on the pathway of human prion protein conversion.
Elmallah MI; Borgmeyer U; Betzel C; Redecke L
Prion; 2013; 7(5):404-11. PubMed ID: 24121542
[TBL] [Abstract][Full Text] [Related]
38. Exploring structural and thermodynamic stabilities of human prion protein pathogenic mutants D202N, E211Q and Q217R.
Guo J; Ren H; Ning L; Liu H; Yao X
J Struct Biol; 2012 Jun; 178(3):225-32. PubMed ID: 22491059
[TBL] [Abstract][Full Text] [Related]
39. Prion protein aggregation and fibrillogenesis in vitro.
Stöhr J
Subcell Biochem; 2012; 65():91-108. PubMed ID: 23225001
[TBL] [Abstract][Full Text] [Related]
40. Pathogenic mutations located in the hydrophobic core of the prion protein interfere with folding and attachment of the glycosylphosphatidylinositol anchor.
Kiachopoulos S; Bracher A; Winklhofer KF; Tatzelt J
J Biol Chem; 2005 Mar; 280(10):9320-9. PubMed ID: 15591591
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
